NR 601
Chapter 1: Changes with Aging - Notes
Fundamental Considerations
- Recognize that presenting features of disease/illness may be different and having a greater awareness of the
impact of chronic illness on the patient.
- Perspective is different than with younger adults.
Physiological Changes with Aging
- The clinician must be aware that all the systems interact an, in doing so, can increase the older person’s
vulnerability to illness/disease.
- During the clinical decision-making process, the clinician knowledgeable about physiological changes with aging
will be less likely to undertreat a treatable condition. -Example- Use the diagnostic process to differentiate the
more benign seborrheic keratosis from actinic keratosis.
- Be informed; do not attribute a finding to the aging process alone. The elder may conclude there is no point in
changing behavior, because the process is inevitable.
- Three primary points:
1) There is a reduced physiological reserve of most body systems, particularly cardiac, respiratory, and renal.
2) There are reduced homeostatic mechanisms that fail to adjust regulatory systems such as temperature control
and fluid and electrolyte balance.
3) There is impaired immunological function: infection risk is greater, and autoimmune diseases are more
prevalent.
Laboratory Values in Older Adults
- Many factors can influence lab value interpretation in the elderly, including the physiological changes with aging,
the prevalence of chronic disease, changes in nutritional and fluid intake, lifestyle (including activity), and the
medications taken.
- Reference ranges therefore may be preferable. Reference ranges or intervals, such as age, sex, or race can be
defined demographically. For example, the reference range for older adults might be the intervals within which 95%
of persons over age 70 fall.
- Further defined physiologically (fasting or activity status) or pharmacologically (medication, tobacco or ETOH use).
- Biochemical individuality is of particular importance in detecting asymptomatic abnormalities in older adults.
Significant homeostatic disturbances in the same individual may be detected through serial laboratory tests, even
though all individual test results may lie within normal limits of the reference interval for the entire group.
- The clinician must determine whether a value obtained reflects a normal aging change, a disease, or the potential
for disease.
- Misinterpretation of an abnormal lab value as an aging change can lead to underdiagnosis and undertreatment in
other (anemia or UTI) and overdiagnosis and overtreatment in others (hyperglycemia or asymptomatic bacteriuria).
- At times, the result of a lab value may be within the appropriate reference range yet indicate pathology for the
older adult.
- Calculation of creatinine clearance is important in the estimation of renal function.
- Reduced renal function, particularly GFR, affects clearance of many drugs, and creat clearance provides an index
of renal function for use in choosing doses of renally eliminated or nephrotoxic drugs (such as dig, H2 blocker,
lithium, and water soluble antibiotics)
- The Modiciation of Diet in Renal Disease (MDRD) and Cockcroft-Gault equations both provide useful estimates of
the GFR.
- Any risks involved in lab testing must be considered with respect to the patient’s clinical condition and weighed
, against the test’s expected benefits.
Pharmacokinetic & Pharmacodynamic Changes
- Polypharmacy and the potential for an adverse drug reaction (ADR) are major concerns in elders.
- Polypharmacy primary predictor for an ADR (any unwanted response).
- The therapeutic window narrows with age. The potential for benefiting the patient measured against risk of doing
harm important.
- Pharmacokinetics (what the body does to the drug) and pharmacodynamics (what the drug does to the body)
alter the dynamic processes that drugs undergo to produce therapeutic effect due to the effects of the aging
process.
Absorption
- Less impact than distribution, metabolism, elimination.
- Gastric acidity declines with age; offset by the longer contact time that occurs as transit time slows – which is
more functional than physiological.
- Presence of food and other drugs in the stomach at the same time affect drug absorption.
- Antacids and Fe can inhibit absorption.
- Anticholinergic meds cause a slowing of colonic motility and can result in greater absorption rates.
- Metabolic diseases, such as thyroid disease/DM can increase or decrease transit time, can cause either
increased/decreased drug absorption.
- When the med passes through the esophagus without adequate water, can cause erosion.
Distribution
- Drug distribution is affected by aging, particularly in individuals of smaller body size, decreased body water, higher
body fat.
- Drugs distributed in water have a higher concentration in elders, and exert a more profound effect.
- Drugs distributed fat have a wider distribution and a lesss intense effect but a more prolonged action, particularly
with more adipose tissue.
- Drugs with a high protein binding rate have a greater potential to cause an ADR in those with less body mass.
Fewer receptor sites, less albumin for binding, greater plasma concentration, more free drug is available for
processes.
- Protein bound drugs can reach toxic levels if the patient is not monitored closely.
- Drug distribution relies on the bioavailability of the drug.
- Amount of drug that reaches systemic circulation is increased/decreased based on:
1) Route of administration – drugs given IV/topically are more readily available than drugs admin
IM/Subq/PO/rectally
2) Soluability of the drug is influential – aqueous solutions are available more quickly than oily ones
3) General circulation to the site of drug administration
Metabolism
Biotransformation occur sin all body tissues but primarily in the liver, where enzymatic activity (cytochrome P [CYP]
system) alters and detoxifies the drug and prepares it for excretion.
- Ability of the liver to metabolize drugs does not decline similarly for all meds.
- Liver size and blood flow decrease with age, LFTs are typically normal when no disease exists. Can result in
decreased first-pass metabolism.
- Drug activity for some meds is prolonged, because drugs are metabolized and eliminated more slowly.
Chapter 1: Changes with Aging - Notes
Fundamental Considerations
- Recognize that presenting features of disease/illness may be different and having a greater awareness of the
impact of chronic illness on the patient.
- Perspective is different than with younger adults.
Physiological Changes with Aging
- The clinician must be aware that all the systems interact an, in doing so, can increase the older person’s
vulnerability to illness/disease.
- During the clinical decision-making process, the clinician knowledgeable about physiological changes with aging
will be less likely to undertreat a treatable condition. -Example- Use the diagnostic process to differentiate the
more benign seborrheic keratosis from actinic keratosis.
- Be informed; do not attribute a finding to the aging process alone. The elder may conclude there is no point in
changing behavior, because the process is inevitable.
- Three primary points:
1) There is a reduced physiological reserve of most body systems, particularly cardiac, respiratory, and renal.
2) There are reduced homeostatic mechanisms that fail to adjust regulatory systems such as temperature control
and fluid and electrolyte balance.
3) There is impaired immunological function: infection risk is greater, and autoimmune diseases are more
prevalent.
Laboratory Values in Older Adults
- Many factors can influence lab value interpretation in the elderly, including the physiological changes with aging,
the prevalence of chronic disease, changes in nutritional and fluid intake, lifestyle (including activity), and the
medications taken.
- Reference ranges therefore may be preferable. Reference ranges or intervals, such as age, sex, or race can be
defined demographically. For example, the reference range for older adults might be the intervals within which 95%
of persons over age 70 fall.
- Further defined physiologically (fasting or activity status) or pharmacologically (medication, tobacco or ETOH use).
- Biochemical individuality is of particular importance in detecting asymptomatic abnormalities in older adults.
Significant homeostatic disturbances in the same individual may be detected through serial laboratory tests, even
though all individual test results may lie within normal limits of the reference interval for the entire group.
- The clinician must determine whether a value obtained reflects a normal aging change, a disease, or the potential
for disease.
- Misinterpretation of an abnormal lab value as an aging change can lead to underdiagnosis and undertreatment in
other (anemia or UTI) and overdiagnosis and overtreatment in others (hyperglycemia or asymptomatic bacteriuria).
- At times, the result of a lab value may be within the appropriate reference range yet indicate pathology for the
older adult.
- Calculation of creatinine clearance is important in the estimation of renal function.
- Reduced renal function, particularly GFR, affects clearance of many drugs, and creat clearance provides an index
of renal function for use in choosing doses of renally eliminated or nephrotoxic drugs (such as dig, H2 blocker,
lithium, and water soluble antibiotics)
- The Modiciation of Diet in Renal Disease (MDRD) and Cockcroft-Gault equations both provide useful estimates of
the GFR.
- Any risks involved in lab testing must be considered with respect to the patient’s clinical condition and weighed
, against the test’s expected benefits.
Pharmacokinetic & Pharmacodynamic Changes
- Polypharmacy and the potential for an adverse drug reaction (ADR) are major concerns in elders.
- Polypharmacy primary predictor for an ADR (any unwanted response).
- The therapeutic window narrows with age. The potential for benefiting the patient measured against risk of doing
harm important.
- Pharmacokinetics (what the body does to the drug) and pharmacodynamics (what the drug does to the body)
alter the dynamic processes that drugs undergo to produce therapeutic effect due to the effects of the aging
process.
Absorption
- Less impact than distribution, metabolism, elimination.
- Gastric acidity declines with age; offset by the longer contact time that occurs as transit time slows – which is
more functional than physiological.
- Presence of food and other drugs in the stomach at the same time affect drug absorption.
- Antacids and Fe can inhibit absorption.
- Anticholinergic meds cause a slowing of colonic motility and can result in greater absorption rates.
- Metabolic diseases, such as thyroid disease/DM can increase or decrease transit time, can cause either
increased/decreased drug absorption.
- When the med passes through the esophagus without adequate water, can cause erosion.
Distribution
- Drug distribution is affected by aging, particularly in individuals of smaller body size, decreased body water, higher
body fat.
- Drugs distributed in water have a higher concentration in elders, and exert a more profound effect.
- Drugs distributed fat have a wider distribution and a lesss intense effect but a more prolonged action, particularly
with more adipose tissue.
- Drugs with a high protein binding rate have a greater potential to cause an ADR in those with less body mass.
Fewer receptor sites, less albumin for binding, greater plasma concentration, more free drug is available for
processes.
- Protein bound drugs can reach toxic levels if the patient is not monitored closely.
- Drug distribution relies on the bioavailability of the drug.
- Amount of drug that reaches systemic circulation is increased/decreased based on:
1) Route of administration – drugs given IV/topically are more readily available than drugs admin
IM/Subq/PO/rectally
2) Soluability of the drug is influential – aqueous solutions are available more quickly than oily ones
3) General circulation to the site of drug administration
Metabolism
Biotransformation occur sin all body tissues but primarily in the liver, where enzymatic activity (cytochrome P [CYP]
system) alters and detoxifies the drug and prepares it for excretion.
- Ability of the liver to metabolize drugs does not decline similarly for all meds.
- Liver size and blood flow decrease with age, LFTs are typically normal when no disease exists. Can result in
decreased first-pass metabolism.
- Drug activity for some meds is prolonged, because drugs are metabolized and eliminated more slowly.
